isradipine has been researched along with Arterial Occlusive Diseases in 3 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ibayashi, S | 1 |
Nagao, T | 1 |
Kitazono, T | 1 |
Ooboshi, H | 1 |
Kitayama, J | 1 |
Sadoshima, S | 1 |
Fujishima, M | 1 |
Sauter, A | 1 |
Rudin, M | 1 |
Marinov, M | 1 |
Wassmann, H | 1 |
3 other studies available for isradipine and Arterial Occlusive Diseases
Article | Year |
---|---|
Calcium antagonist isradipine reduces metabolic alterations in acute cerebral ischemia in spontaneously hypertensive rats.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Brain; Calcium Channel Blockers; Carotid Artery | 2000 |
Efficacy of isradipine in middle cerebral artery-occluded rats.
Topics: Animals; Arterial Occlusive Diseases; Cerebral Arteries; Dihydropyridines; Isradipine; Rats | 1992 |
Lack of effect of PN 200-110 on neuronal injury and neurological outcome in middle cerebral artery-occluded rats.
Topics: Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Cerebral Arteries; Isradipine; Male; | 1991 |